Little is known about the protection following prior infection with different #SARS2 variants, #COVID19 vaccination, and a combination of the two (hybrid immunity) in #adolescents. 1/
A new study from #England estimated protection following previous infection and vaccination against symptomatic PCR-confirmed delta & omicron (BA.1 or BA.2) variants in 11-17-year-olds using a test-negative case-control design. 2/
In unvaccinated adolescents, prior infection with WT, Alpha or Delta provided greater protection against subsequent Delta infection than subsequent Omicron; prior omicron infection provided the highest protection against omicron reinfection 3/
In infection-naive adolescents, #vaccination provided lower protection against symptomatic omicron infection than delta, peaking at 64.5% 2-14 days after dose two and 62.9% 2-14 weeks after dose three, with rapidly waning protection after each dose. 4/
Previously infected & vaccinated adolescents had the highest protection, irrespective of primary infecting SARS2 strain.
The highest protection ag Omicron was observed in vaccinated adolescents w/ prior omicron infection, reaching 96.4% at 15-24 weeks post dose two. 5/
Key findings:
1-All variants provide some protection against symptomatic reinfection & vaccination adds to protection.
2-Vaccination provides low-to-moderate protection against symptomatic omicron infection, with waning protection after each dose.
6/
3-However, the hybrid immunity provides the most robust protection.
#SARS2 can readily alter its Spike protein via a single Amino acid substitution so that it is not recognized by CD8 T cells targeting the most prevalent epitope in Spike restricted by the most common HLA-I across the population. 1/
The Spike #P272L mutation that has arisen in at least 112 different #SARS2 lineages to date, including in lineages classified as “VOC”, was not recognized by the large CD8 T cell 2/
The CD8 T cells response seen across cohorts of HLA A∗02+ convalescent patients & individuals vaccinated against SARS2, despite these responses comprising of over 175 different individual T cell receptors. 3/
The human face is one of the most visible features of our unique identity as individuals. Interestingly, monozygotic twins share almost identical facial traits & the same DNA sequence but could exhibit differences in other biometrical parameters. 1/
The expansion of the internet & the possibility to exchange pictures of humans across the planet has increased the number of people identified online as virtual twins or doubles that are not family related. 2/
In this study, the researchers characterized in detail a set of “look-alike” humans, defined by facial recognition algorithms, for their multiomics landscape. 3/
In late 2020, the #JCVI of #England made two important recommendations for the initial roll-out of the #COVID19 vaccine.
1-Vaccines should be targeted to the elderly and vulnerable to maximally preventing disease rather than infection 1/
2-To increase the interval between first and second doses of ChAdOx vaccine for 3 to 12-weeks in order to have a higher efficacy with this longer dose interval. 2/
A new modelling study from England shows that targeting the most vulnerable had the biggest immediate impact (compared to targeting younger individuals who may be more responsible for transmission). 3/
A defining feature of successful vaccination is the ability to induce long-lived antigen-specific memory cells. Follicular helper T (Tfh) cells specialize in providing help to B cells in mounting protective humoral immunity in infection and after vaccination. 1/
T follicular helper (Tfh) cells are the subset of CD4 T helper cells that are required for generation and maintenance of germinal center reactions and the generation of long-lived humoral immunity. 2/
Memory Tfh cells that retain the CXCR5 expression can confer protection through enhancing humoral response upon antigen re-exposure but how they are maintained is poorly understood. 3/
If there is an outbreak of wild or vaccine derived polio anywhere, you need OPV to control it. IPV despite offering robust systemic immunity may fail to work in these situations owing to its inferior mucosal immunity. 2/
Studies including large meta-analysis have shown that it is mucosal secretary IgA that are far more important than systemic immunity in prevention of infection 3/
Could frequent boosting be counterproductive? Due to ‘immune imprinting’, if you have been exposed to the original strain, then no matter how many times you inject yourself w/ these COVID vaccines, you will not mount efficient NAbs or T cell responses against newer ‘variants’
OAS operates through Germinal Centre reactions, where high-affinity memory B-cells are produced. These cells are 'supercharged' & inhibit recruitment of naïve B-cells against a new offending agent. The effect is a weak antibody response. 2/
In fact, the vaccines based on ancestral strain may compromise your immune system's ability to react to new variants. So, quite possibly, the unvaccinated may have a better immune response to your scary new variant than the vaccinated and boosted. 3/